Literature DB >> 8234096

Does rheumatoid factor always mean arthritis?

J R Lisse1.   

Abstract

Rheumatoid arthritis is a clinical syndrome, and the diagnosis requires the presence of pain, swelling, and tenderness in the joints. In the absence of these features, identification of rheumatoid factor in the serum is of little use. Because rheumatoid factor is an immune complex, it is a marker of immune activation and, therefore, may be present in the circulation of persons with a variety of inflammatory conditions that stimulate the immune system. Also, 5% of the healthy population have significant titers of rheumatoid factor in their serum.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8234096     DOI: 10.1080/00325481.1993.11945749

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  7 in total

1.  Second generation automated anti-CCP test better predicts the clinical diagnosis of rheumatoid arthritis.

Authors:  Mohamed Elrefaei; Kristie Boose; Martha McGee; Teresa K Tarrant; Feng-Chang Lin; Jason P Fine; John L Schmitz
Journal:  J Clin Immunol       Date:  2011-11-10       Impact factor: 8.317

2.  Is rheumatoid factor still a superior test for the diagnosis of rheumatoid arthritis?

Authors:  Usha Singh; Anjali Vishwanath; Pramod K Verma; Nand K Singh; Ram C Shukla; Sangeeta Singh; Suman Singh; Gyanendra K Sonkar
Journal:  Rheumatol Int       Date:  2010-01-08       Impact factor: 2.631

3.  Autoantibodies to cyclic citrullinated peptide 2 (CCP2) are superior to other potential diagnostic biomarkers for predicting rheumatoid arthritis in early undifferentiated arthritis.

Authors:  Eriko Kudo-Tanaka; Shiro Ohshima; Masaru Ishii; Toru Mima; Masato Matsushita; Naoto Azuma; Yoshinori Harada; Yoshinori Katada; Hitomi Ikeue; Mitsuko Umeshita-Sasai; Kunio Miyatake; Yukihiko Saeki
Journal:  Clin Rheumatol       Date:  2007-02-08       Impact factor: 2.980

4.  Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages.

Authors:  E R Vossenaar; T R D Radstake; A van der Heijden; M A M van Mansum; C Dieteren; D-J de Rooij; P Barrera; A J W Zendman; W J van Venrooij
Journal:  Ann Rheum Dis       Date:  2004-04       Impact factor: 19.103

5.  Citrullination, a possible functional link between susceptibility genes and rheumatoid arthritis.

Authors:  Erik R Vossenaar; Albert JW Zendman; Walther J Van Venrooij
Journal:  Arthritis Res Ther       Date:  2003-11-25       Impact factor: 5.156

6.  Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin.

Authors:  Erik R Vossenaar; Normand Després; Elvy Lapointe; Annemarie van der Heijden; Maximillian Lora; Tatsuo Senshu; Walther J van Venrooij; Henri A Ménard
Journal:  Arthritis Res Ther       Date:  2004-02-05       Impact factor: 5.156

7.  Reactivity of Rheumatoid Arthritis-Associated Citrulline-Dependent Antibodies to Epstein-Barr Virus Nuclear Antigen1-3.

Authors:  Ilaria Fanelli; Paolo Rovero; Paul Robert Hansen; Jette Lautrup Frederiksen; Gunnar Houen; Nicole Hartwig Trier
Journal:  Antibodies (Basel)       Date:  2022-03-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.